Fontan Udenafil Exercise Longitudinal Assessment Trial (FUEL)
Improvement of exercise capacity in patients with Fontan physiology
Sponsor: NIH & Mezzion Pharma Co. Ltd
Enrolling: Male and Female Patients
Study Length: 6 Months
Clinic Visits: 4
IRB Number: AAAQ1065
U.S. Govt. ID: NCT02741115
Contact: Katrina Golub: 212-342-1562 / kg2697@cumc.columbia.edu
Additional Study Information: Over time, children and young adults who have had a Fontan operation may find they are more tired, have difficulty breathing and cannot exercise as well as before. Currently, there are no approved medicines to prevent this decline. The purpose of this research study is to learn whether children who have had the Fontan operation can improve their ability to exercise by taking a medicine called Udenafil. The medicine works by making it easier for blood to flow through the lungs and back to the heart. The medicine may also improve overall circulation, including function of the blood vessels in the body and the heart itself.
This study is closed
Investigator
Marc Richmond, MD
Do You Qualify?
Are you or your child someone with Fontan physiology? Yes No
Are you or your child between 12 to 18 years of age? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Katrina Golub
kg2697@cumc.columbia.edu
212-342-1562